Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab.
Int J Retina Vitreous
; 8(1): 81, 2022 Nov 17.
Article
in En
| MEDLINE
| ID: mdl-36397121
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Int J Retina Vitreous
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos